Dr. Linda L. Lewallen, MD

Dr. Lewallen practices at CHI St. Alexius Health Dickinson in Dickinson, North Dakota, part of CommonSpirit Health.

Dr. Lewallen's NPI, 1437224201, was assigned on November 21, 2006. Dr. Lewallen holds Massachusetts license PHY101196.

Dr. Lewallen's primary practice is CHI St. Alexius Health Dickinson, at 2500 Fairway Street, Dickinson, ND 58601 in Stark County. The practice phone is (701) 456-4000.

Dr. Lewallen's primary practice is CHI St. Alexius Health Dickinson in Dickinson, North Dakota, part of CommonSpirit Health. Dr. Lewallen is also affiliated with Merrimack Health Methuen Hospital. The medical group on file is CHI St. Alexius Health Dickinson. Dmand AI also links Dr. Lewallen to 2 more hospitals, 8 medical groups and 1 group practice or clinic, each named with a free account. Dr. Lewallen's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lewallen practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Lewallen's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Lewallen's licenses on file in 3 states: Massachusetts, Florida and Pennsylvania.

CMS data shows 177 Medicare services from Dr. Lewallen across 4 procedure codes in 2024, for 111 Medicare patients. Medicare paid $12,713 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Lewallen in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lewallen's median patient age at 71, with 47% women.

In 2024, Dr. Lewallen wrote 53 Medicare Part D claims for 18 patients. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $835 in total drug cost. In 2018, CMS named 13 claims across 1 drug.

Dr. Lewallen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Lewallen from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $44.